Evaluation of the TEG® platelet mapping™ assay in blood donors

Thrombosis Journal

Volumn 5, Issue , 2007, Pages

  Bochsen, Louise ^a   Wiinberg, Bo ^a   Kjelgaard Hansen, Mads ^a   Steinbrüchel, Daniel A ^a   Johansson, Pär I ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; FIBRIN; THROMBIN; THROMBOCYTE RECEPTOR; THROMBOXANE A2 RECEPTOR;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD DONOR; CARDIOVASCULAR RISK; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PATIENT MONITORING; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; SEX DIFFERENCE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

EID: 33847634255     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-5-3     Document Type: Article

References (20)

1. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group J Am Coll Cardiol 1988 12 3A-13A 2903874
2. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 2002 324 71-86 64503 11786451 10.1136/bmj.324.7336.S71
3. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee Lancet 1996 348 1329-1339 10.1016/S0140-6736(96)09457-3 8918275
4. Hirsh J Bhatt DL Comparative benefits of clopidogrel and aspirin in high-risk patient populations: Lessons from the CAPRIE and CURE studies Arch Intern Med 2004 164 2106-2110 10.1001/archinte.164.19.2106 15505123
5. Bhatt DL Aspirin resistance: More than just a laboratory curiosity J Am Coll Cardiol 2004 43 1127-1129 10.1016/j.jacc.2004.01.022 15028379
6. Wang TH Bhatt DL Topol EJ Aspirin and clopidogrel resistance: An emerging clinical entity Eur Heart J 2006 27 647-654 10.1093/eurheartj/ ehi684 16364973
7. Matzdorff A Platelet function tests and flow cytometry to monitor antiplatelet therapy Semin Thromb Hemost 2005 31 393-399 10.1055/ s-2005-916672 16149015
8. Tantry US Bliden KP Gurbel PA Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation J Am Coll Cardiol 2005 46 1705-1709 10.1016/ j.jacc.2005.05.090 16256872
9. Craft RM Chavez JJ Bresee SJ Wortham DC Cohen E Carroll RC A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation J Lab Clin Med 2004 143 301-309 10.1016/j.lab.2004.01.011 15122174
10. Wiinberg B Jensen AL Rojkjaer R Johansson P Kjelgaard-Hansen M Kristensen AT Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs Vet Clin Pathol 2005 34 389-393 16270265
11. Haubelt H Anders C Hellstern P Can platelet function tests predict the clinical efficacy of aspirin? Semin Thromb Hemost 2005 31 404-410 10.1055/s-2005-916674 16149017
12. Hochholzer W Trenk D Frundi D Neumann FJ Whole blood aggregometry for evaluation of the antiplatelet effects of clopidogrel Thromb Res 2006 16603231
13. Alstrom U Tyden H Oldgren J Siegbahn A Stahle E The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment Thromb Res 2006 17137616
14. Poulsen TS Mickley H Korsholm L Licht PB Haghfelt T Jorgensen B Using the Platelet Function Analyzer-100 for monitoring aspirin therapy Thromb Res 2006
15. Wohltmann CD Franklin GA Boaz PW Luchette FA Kearney PA Richardson JD Spain DA A multicenter evaluation of whether gender dimorphism affects survival after trauma Am J Surg 2001 181 297-300 10.1016/ S0002-9610(01)00582-7 11438262
16. Gurbel PA Bliden KP Hiatt BL O'Connor CM Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 2003 107 2908-2913 10.1161/ 01.CIR.0000072771.11429.83 12796140
17. Jaremo P Lindahl TL Fransson SG Richter A Individual variations of platelet inhibition after loading doses of clopidogrel J Intern Med 2002 252 233-238 10.1046/j.1365-2796.2002.01027.x 12270003
18. Chen L Bracey AW Radovancevic R Cooper JR Jr. Collard CD Vaughn WK Nussmeier NA Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting J Thorac Cardiovasc Surg 2004 128 425-431 10.1016/j.jtcvs.2004.02.019 15354103
19. Gurbel PA Bliden KP Guyer K Cho PW Zaman KA Kreutz RP Bassi AK Tantry US Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study J Am Coll Cardiol 2005 46 1820-1826 10.1016/j.jacc.2005.07.041 16286165
20. McCrath DJ Cerboni E Frumento RJ Hirsh AL Bennett-Guerrero E Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction Anesth Analg 2005 100 1576-1583 10.1213/01.ANE.0000155290.86795.12 15920177